Old Web
English
Sign In
Acemap
>
authorDetail
>
Viktor Paramonov
Viktor Paramonov
Medicine
Internal medicine
Anesthesia
Cancer
Pharmacodynamics
3
Papers
65
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 2 study of PD-1 inhibitor JTX-4014 alone and in combination with vopratelimab, an ICOS agonist, in biomarker-selected subjects with metastatic NSCLC after one prior platinum-containing regimen (SELECT).
2021
Journal of Clinical Oncology
Oleh Kobziev
Iurie Bulat
Yuriy Ostapenko
Zanete Zvirbule
Grygorii Ursol
Vasyl Boyko
Viktor Paramonov
Yasmin Hashambhoy-Ramsay
Courtney Hart
Christopher D. Harvey
Ashley Graca
Lidya Le
Weidong Zhang
Bo Chao
Judy Jimenez
Krithi Bala
Sarah Maxwell
Haley Laken
Johan Baeck
Ellen Hooper
Show All
Source
Cite
Save
Citations (0)
Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a Phase I multicentre trial in patients scheduled for elective breast cancer surgery
2013
Investigational New Drugs
N.J. Bundred
Jānis Gardovskis
Janusz Jaśkiewicz
Jānis Eglītis
Viktor Paramonov
Peter McCormack
Helen Swaisland
Maria Cavallin
Tony Parry
J. Carmichael
J. Michael Dixon
Show All
Source
Cite
Save
Citations (65)
1